Former Hollywood Stuntman Raising $10,000 For His Stem Cell … – DNAinfo

Len Richard (left) and actor Terrance Howard on the set of "Empire" in 2015. View Full Caption

Provided by Len Richard

CHICAGO Len Richard used to fight in movie scenes as a stuntman, but now hes fighting for his life.

Diagnosed with liver disease in 2009, hes been placed on the liver and kidney transplant list to replace his rapidly failing organs. Hes opted to have stem cell replacement therapy in place of the transplant, but his insurance wont cover it, so hes raising $10,000 through YouCaring.

The 44-year-old Englewood native said hes desperate to live a healthy life and doesnt want to risk trying the transplant. Theres the fear that the new organs wont work for long and hell constantly get sick from the anti-rejection medications hell have to take, he said.

Once I understood how stem cell works and how it cures people, it was a no-brainer, Richard said. I rather do that than have someone's organs.

More than 5,000 liver transplants in the United States take place each year, according to the "Stem Cell Therapy for Liver Diseases," a review article published in the Journal of Stem Cell Research and Therapy. About 20,000 people are waiting for a transplant, but only 7,000 procedures are performed each year, and up to 1,500 patients die each year waiting.

Use of stem cells to cure liver diseases has been proved beneficial in most of the conditions, according to the article. Scientific literature reveals the role of stem cells in treatment and cure of various diseases like liver cirrhosis, end stage liver failure, genetic liver disease and also the liver cancer. The stem cells possess the ability to renew and multiply by them or stem cells possess special characteristics of regenerating themselves.

Besides being hospitalized twice in eighth grade for a high fever and an enlarged liver and spleen, Richard has lived a fairly healthy life, he said. He had no major health problems in high school or college.

As an adult, he worked behind the scenes in the control room at Channel 50, before moving to Los Angeles in 1998 for a similar television job. Thats when his life changed.

He was at a gym working out and got invited to train with a group who worked as stuntmen, he said.

A stunt coordinator saw me and said that I looked like Omar and Cuba Gooding, Richard said. He hired me for 'Baby Boy.' Thats how I got into doing stunts.

That job led to other jobs in major films, including "Barbershop" and "Transformers."

Everything was going well for Richard, he said, until 2008 when he tore his rotator cuff during filming for the movie "First Sunday," starring Ice Cube and Katt Williams.

I had surgery, and the person I was seeing at the time noticed that I started losing weight and was going to the bathroom a lot, Richard said.

When he went to the doctor for a routine checkup, he learned that he was diabetic. The doctor reviewed his medical history and asked if he has ever been evaluated for a liver transplant.

In 1987, when he was 13, he mysteriously became ill, he said. He was in the hospital for a high fever and the doctors noticed that his liver and spleen were enlarged, but didnt know why. He was sent home only to return a few days later.

I spent the whole summer in the hospital, Richard said. They did exploratory abdominal surgery and took a sample of all of my organs. They sent it to the CDC and other labs and came back with nothing.

Now that hes on the transplant list, Richard is hoping that hes able to raise enough money to travel to see a doctor in Mexico who was recommended by another patient and have the alternative procedure instead.

I want to avoid the transplant and keep my organs, Richard said.

He said he misses his old life, although he did more recently work on the show "Empire." Hes on disability now, but wants to return to work and the gym.

I was always in the gym, used to go hiking a lot, but now I work out when I feel like it, he said. I have low energy, and its kind of hard right now. I'll ride a bike and try to do air squats, but I was doing crossfit before it became too much for me.

Nobody wants to be sick. Id like to be back in California, moving around. I just get tired of going to doctor, getting poked and having having them tell me I need a transplant. Its mentally draining, and it's scary.

More:
Former Hollywood Stuntman Raising $10,000 For His Stem Cell ... - DNAinfo

Stem Cell Transplant Program Celebrates First Year – Newswise – Newswise (press release)

Newswise The University of New Mexico Comprehensive Cancer Center began helping New Mexicans with blood disorders a little more than one year ago. Since then, more than 30 New Mexicans have received treatment. Program Director Matthew Fero, MD, FACP, started the program after moving to New Mexico from the Fred Hutchinson Cancer Center in Seattle, Wash.

The UNM Comprehensive Cancer Center program is the states only bone marrow transplant program. It includes a nurse manager, nurse coordinator, a social worker, a pharmacist, infusion nurses, and an inpatient team. Bone marrow transplantation needs a multidisciplinary team because of the complexity in coordinating care, says Fero. The teams Nurse Manager, Maria Limanovich, says the team follows each person from the beginning of bone marrow transplant treatment through completion. According to Fero, the program is growing and is in the process of hiring two more doctors and an advanced practice provider.

The UNM Bone Marrow Transplant program offers treatment choices for people with lymphoma and myeloma and will expand to help people with other blood disorders. Almost 1,000 New Mexicans receive a blood cancer diagnosis each year, according to American Cancer Society estimates.

Fero and his team currently perform autologous transplants. Autologous bone marrow transplantation is the process of taking bone marrow stem cells out of a patient and then infusing them back in after the patient receives high dose therapy, says Fero. This allows us to use treatments that would otherwise harm the bone marrow.

Bone marrow, the soft reddish material that fills the inside of our bones, produces millions of new blood cells each second. These millions of cells come from a tiny number of bone marrow stem cells. These stem cells are special because they can mature into all of the different types of cells in the blood. These are the cells doctors collect for a transplant.

Because bone marrow is a liquid organ, Fero says, it can pass through an IV [intravenous] line. Doctors rarely need to take stem cells directly out of the bone, Fero explains. They use drugs to coax bone marrow stem cells into the bloodstream. From there, the blood travels through an IV line into an apheresis machine that sorts the stem cells out and returns the rest of the blood. The experience is like donating blood at a blood bank.

Once stem cells are safely stored out of the bloodstream, doctors use high-dose chemotherapy to eradicate the remaining cancer. When chemotherapy is out of their system, the patients stem cells are reinfused. The reinfusion process is similar to a blood transfusion. Once reinfused, stem cells find their way back to bone marrow where they begin to grow and make new blood cells.

Autologous bone marrow transplants are standard treatments for lymphoma and myeloma. This treatment works very well against aggressive lymphomas. In this case the goal is to cure the disease, says Fero. Autologous bone marrow transplants extend the lives of people with myeloma and gives them a better quality of life, too. Fero says, Were offering another option for their treatment.

Matthew Fero, MD, FACP, is a Professor in the Department of Internal Medicine, Division of Hematology/Oncology, at the UNM School of Medicine. He serves as Director of the Bone Marrow Stem Cell Program at the UNM Comprehensive Cancer Center. Dr. Fero received his medical degree from the University of California, Irvine, and completed his residency in Internal Medicine at the Mayo Graduate School of Medicine. He completed a medical fellowship in Medical Oncology at University of Washington and a research fellowship at Fred Hutchinson Cancer Research Center. He is a member of the American Society of Hematology and the American Society for Blood and Marrow Transplantation, and is a Fellow of the American College of Physicians. His research focuses on the molecular bases of cancer and translating new technologies into improved cancer diagnostics and novel therapies.

The University of New Mexico Comprehensive Cancer Center is the Official Cancer Center of New Mexico and the only National Cancer Institute-designated Cancer Center in a 500-mile radius. Its 125 board-certified oncology specialty physicians include cancer surgeons in every specialty (abdominal, thoracic, bone and soft tissue, neurosurgery, genitourinary, gynecology, and head and neck cancers), adult and pediatric hematologists/medical oncologists, gynecologic oncologists, and radiation oncologists. They, along with more than 500 other cancer healthcare professionals (nurses, pharmacists, nutritionists, navigators, psychologists and social workers), provided cancer care for nearly 60 percent of the adults and children in New Mexico affected by cancer. They treated 11,249 patients in 84,875 ambulatory clinic visits in addition to in-patient hospitalizations at UNM Hospital. These patients came from every county in the State. More than 12 percent of these patients participated in cancer clinical trials testing new cancer treatments and 35 percent of patients participated in other clinical research studies, including tests of novel cancer prevention strategies and cancer genome sequencing. The 130 cancer research scientists affiliated with the UNMCCC were awarded almost $60 million in federal and private grants and contracts for cancer research projects and published 301 high quality publications. Promoting economic development, they filed more than 30 new patents in FY16, and since 2010, have launched 11 new biotechnology start-up companies. Scientists associated with the UNMCCC Cancer Control & Disparities have conducted more than 60 statewide community-based cancer education, prevention, screening, and behavioral intervention studies involving more than 10,000 New Mexicans. Finally, the physicians, scientists and staff have provided education and training experiences to more than 230 high school, undergraduate, graduate, and postdoctoral fellowship students in cancer research and cancer health care delivery. Learn more at http://www.cancer.unm.edu.

View post:
Stem Cell Transplant Program Celebrates First Year - Newswise - Newswise (press release)

Rare leukemia targeted by modifying patients’ immune cells – West Hartford News

NEW HAVEN >> Young patients with a particular type of leukemia who have relapsed after going into remission may find new hope through a treatment that involves modifying a patients own T cells, an important part of the immune system, to destroy cancer cells.

While the therapy, in which genes are inserted into a patients T cells, is expected to receive Food and Drug Administration approval soon for pediatric patients, researchers hope that it will be effective for adult patients as well and for more types of cancers, according to Dr. Steven Gore, director of hematologic malignancies at the Yale Cancer Center.

The cancer thats the focus of this T cell therapy is B-lineage acute lymphoblastic leukemia, which is the most common leukemia in kids and its commonly cured in the 2- to 10-year-old age group, Gore said. He said about 70 percent of children with the cancer are cured.

However, the rest suffer a recurrence of the disease even after treatment with chemotherapy and stem cell transplants.

Its getting to be a difficult situation, Gore said.

There are 3,100 cases of children with B-lineage ALL each year, he said.

B cells, also known as B lymphocytes, are white blood cells that produce antibodies, which fight infection. A characteristic of B cells is that they have a protein on their surface called CD19, which is the key to the new treatment.

The new process, marketed by Novartis and first developed at the University of Pennsylvania, involves harvesting T cells from the patient. Novartis then introduces DNA into these T cells, introducing new genes into the T cells, [which] include a receptor that will recognize CD19, Gore said. The genes that are fused into the T cells are manufactured in the lab but are copies of normal human genes, Gore said. The new cell is called a chimeric antigen receptor T cell, or CAR-T cell.

Normal T cells fight disease, and we know that T cells can attack cancer cells as well, but getting them to do so in the host where the cancer has developed is tricky, Gore said. Cancer cells are very similar [to] normal cells from which they derive.

Turning the T cells into CAR-T cells helps by targeting the CD19 marker on the B cells. CD19 happens to be a pretty good target for cancer technology because its only on B cells, Gore said. These new CAR-T cells latch onto the leukemia cells.

Reproducing cells

Then, once they see that theyre needed, the CAR-T cells are going to make more of themselves. Theyre going to make a whole army-full beside what we gave the patient, Gore said. Other genes in the introduced DNA give the immune system the go-ahead to kill these leukemia cells.

The CAR-T cells target both healthy and malignant B cells, but people live all the time without B cells, Gore said, by relying on drugs such as rituximab.

The treatment is not easy on the patient, however. When this massive influx of these new T cells attack all these leukemia cells, youre basically setting up a jihad in your body, Gore said. People can get very critically ill after this therapy, even needing to be treated in the intensive care unit.

Despite the hardship, the FDAs Oncologic Drugs Advisory Committee voted 10-0 on July 12 to recommend approval of CAR-T therapy, and it is very rare that an ODAC approval does not end up in an FDA approval, Gore said.

In one trial, 41 of 50 patients with relapsed or refractory B-lineage ALL each achieved complete remission after three months, Gore said, and 60 percent of those patients were still in remission six months later.

It will be rapidly opened up to adults as well, theres no question about it, he said. Some people think this therapy may replace stem cell therapy and doctors hope it can be given before a patient relapses, avoiding stem cell transplants.

We dont have long-term follow-up to know if these patients are cured, Gore said. Theyve certainly been rescued from otherwise-certain death.

Gore said the Yale School of Medicine has been approached by Novartis to be one of the rollout sites for this therapy.

While the new treatment targets a relatively rare cancer, its likely to be effective in other cancers involving B cells, including other types of leukemia and lymphoma, Gore said. (Not all lymphomas and leukemias are B cell cancers, however.) This rare leukemia has been the subject of all this investigation because CD19 is such a low-hanging fruit, because we can live without B cells, he said.

But the technology can theoretically be adapted to any kind of tumor, he said. Theoretically, you could make a CAR-T to target any particular kind of cancer provided that that cancer expresses certain proteins that are predominantly limited to the cancer and not important vital organs.

Call Ed Stannard at 203-680-9382.

Here is the original post:
Rare leukemia targeted by modifying patients' immune cells - West Hartford News

‘I still have my brain’ – The Northwest Florida Daily News

Jack Massey of Niceville suffered a spinal cord injury in a pool accident in March and is paralyzed from the chest down. After months of rehab, he's eager to get back into a familiar routine.

NICEVILLE Jack Massey is ready to go back to school.

Only this time, the University of Florida senior will head back to campus with his mom and a new outlook on life.

Massey suffered a spinal cord injury in a pool accident in March and is paralyzed from the chest down. After months of rehab, he's eager to get back into a familiar routine.

"It's definitely boring," the 21-year-old said at his parents' home in Niceville. "There's not a lot to do. I want to go back to school. I still have my brain. I still have everything I need to be successful."

After the accident March 17, Massey was treated at the University of Florida Shands Hospital and then was transferred to Shepherd Center, a spinal cord and brain injury rehab center in Atlanta. At Shepherd Center he met with a peer mentor, counselors and physical therapists to help him find a new normal.

Jack has remained positive throughout the past six months.

"Jack has been a fighter through all of this," said his mother, Julie. "I think he's done well. I only saw him break down once."

Before the accident, Jack was a well-rounded athlete who playing baseball and basketball and ran. He was a star on the track and field team at Niceville High School, with his 4 X 800 relay winning state his senior year.

He says the biggest challenge now is not being able to do the same things he could before.

"I can't get up and go," he said. "It didn't really start to set in until after I got out of rehab."

Jack has had to find enjoyment in other things, like reading or playing with the dogs. His friends have learned to transfer him from his wheelchair to a car so they can take him to the movies or out to eat. When they recently took a trip to the beach, Julie said five of Jack's friends carried him out to the sand a lesson on how hard it is to navigate the world in a wheelchair.

Jack said he believes technology one day will advance enough that he won't be paralyzed forever. He also volunteered to do stem cell surgery to allow doctors to study the affects of stem cells on his spine for the next 15 years. Instead of wallowing in self pity, he's moving forward. But he'll need help.

"I'm appreciating everything in the now," he said.

Doctors have said Jack has adapted faster than expected, but there are still some everyday essential tasks that are out of his reach. He cannot write or cook. He can shower himself but can't dry himself or transfer himself in and out of his wheelchair. The Massey family hopes to secure a personal care attendant for Jack at school, but until then Julie will be in Gainesville to help him transition. An occupational therapy student from the university will also help Jack on a temporary basis.

Finding proper care for her son has proven to be a learning experience for Julie and her husband, Lance.

"I don't know how people do it," she said. "We have good health care, but then there's hidden costs. There's travel expenses. ... It's kind of humbling. Nobody should have to go to GoFundMe for medical help."

Jack wants to spend his final year as an undergrad as independent as possible. After months of helping him recover, Julie said it will be hard to let her son go. Jack is the oldest of three; his brother Lance is 19 and a student at UF and his sister Alina is 14 and attends Ruckel Middle School.

"It's like letting him go off to kindergarten again," she said.

As for life after college, Jack said he doesn't feel limited in career choices. One of his professors in the geology department encouraged him by saying that there were plenty of opportunities he could pursue in that field. Jack said he may also consider law school. One thing he's learned through this life-altering experience is that there are no limits to what he can achieve.

"I haven't done that much deep thinking. I just go with the flow," he said. "But I learned I have more perseverance. I'm more mentally tough than I thought I was. I'm appreciative for life in general. That's one of the big things."

Here is the original post:
'I still have my brain' - The Northwest Florida Daily News

Ask the Doctors: Stem cell therapy may help worn-out knees | The … – Bennington Banner (subscription)

By Robert Ashley, M.D.

A: "Worn out" is a good way to term what happens to the knee joint with prolonged use. Let's look at how this happens, starting with cartilage.

The lower portion of the knee joint (at the tibia) contains shock absorbers called menisci made of cartilage. You have one on the inner portion and another on the outer portion of each knee. The upper portion of the knee joint (at the femur) is lined with cartilage as well. All of this cartilage helps protect the bones at the joint but it doesn't heal or regenerate well due to limited blood supply. When severe, worn cartilage leads to arthritis of the knee. In knee X-rays of people over the age of 60, 37 percent have shown evidence of arthritis of the knees.

The intriguing thing about stem cells is that they have the ability to become any type of cell that the body needs. The cells used for stem cell injections in the knees are called mesenchymal stem cells, and they can differentiate into bone, fat or cartilage cells. These stem cells can come from the fat cells of your body, from your bone marrow or from the inner lining of your knee joint; they're then replicated in the laboratory and injected into the knee joint.

Here's what the research shows so far ...

In a 2013 study, 32 patients with meniscal tears of the knee were injected with a combination of stem cells, platelet-rich plasma and hyaluronic acid. The study reported improved symptoms and even MRI evidence of meniscal cartilage regeneration.

In a 2014 study, 55 patients who had surgery for meniscal tears of the knees were separated into three groups, with two of the groups receiving stem cell injections. Researchers found that, after six weeks, pain had decreased substantially in the two groups that received stem cell injections and that the decrease was even greater at one and two years after the injection.

In a 2017 study in the British Journal of Sports Medicine, researchers analyzed six studies that used stem cells for osteoarthritis of the knees. In five of the studies, stem cells were given after surgery to the knee; in the other study, stem cells from a donor were administered without surgery. All the studies showed reduced pain and improved knee function. Further, in three of the four trials, MRIs corroborated the cartilage improvements. However, the authors noted, five of the six studies were of such poor methodology that an overall conclusion about the stem cells' effectiveness could not be made.

In all these studies, the most common side effect was knee swelling and stiffness, which improved over time.

There may be benefit to stem cell injections for cartilage loss of the knees, but more data are needed, especially in those who aren't having surgery of the knee. I'd also like to see more data on this type of therapy as a preventive measure for younger patients before their knees are worn out.

Robert Ashley, M.D., is an internist and assistant professor of medicine at the University of California, Los Angeles. Send your questions to askthedoctors@mednet.ucla.edu, or write: Ask the Doctors, c/o Media Relations, UCLA Health, 924 Westwood Blvd., Suite 350, Los Angeles, CA, 90095. Owing to the volume of mail, personal replies cannot be provided.

If you'd like to leave a comment (or a tip or a question) about this story with the editors, please email us. We also welcome letters to the editor for publication; you can do that by filling out our letters form and submitting it to the newsroom.

See original here:
Ask the Doctors: Stem cell therapy may help worn-out knees | The ... - Bennington Banner (subscription)

DHK – Annie McNamara, 27, myelodysplastic syndrome, Boston, with Dr. Robert Soiffer, chief, Hematologic … – WEEI.com

Earlier had a guest on that protects it you might just that might we'll just talk music you know but yes I've done and yes. We have another and now I. You felt it just at the time we got her elbow and grad and out whose family owns the Portland sea dogs and I had to admit I'd bounce the first pitch up. Portland seed in their video of this hole and I thought I asked rotate another chance to sit. Her family owns the airport into dogs and there's been. Apparently I Wii I know exactly where to go to the video thank you very much day. Any back to Mary's here and and her doctor doctor Robert Zoellick for. And that any. It's 27 years old hat Milo this plastic syndrome which I have to admit. I've been sixteen of these things but that's a new one on me at I don't think effort that went before what what exactly did in tale. Yes so it's blood disorder again normally found it again. Older folks. So it was sort of rare for at 25. Year old to be diagnosed with that. But certainly shared today is a bone marrow transplant so. I mean was it meant it to Dana Farber once I found out hands. Did three rounds of chemo outpatient acting forever. An and accepting of both Americans and last June. It's as the impatient at the breakdown. That doctor cipher was my transplant doctor and tenth harbor. And doctor Roberts worked for is here and I heard you say yes when she talked about the rarity of the disease how rare is it. How he treated well itself. It's the disease that as Annie said he's much more common old people. People in the 60s80s. Very uncommon. Twenty's. He can be treated with support here medications and little dose chemotherapy when picked Poulter. When patients younger. We generally want to all Americans clause with out of bone marrow transplant mild to split will lead to keep. And it becomes very eager to treat so. Despite the rarity of the disease and he was that. Attracted the entire time she just made it head on. Did it too tough to what I have to do. I'll take the chemotherapy in the transplant her sister was her daughter which is remarkable story also that. She showed remarkable courage through the entire process in and it even knows something was wrong or you feel like how long that laughed. Tired. Too. Much. The bar. Like an appealing their I don't got a good story and that's what you're gonna carry you through the. I cannot relate to that I. But it hadn't had it takes I knew something really often action difficult. Week. So. It's late night after what happened to inch its way. Saturday Javed Ali counted that's very Massachusetts. My word and act out there. That come back. It's. It doctor Lieberman can tear your donor with your sister Molly. I assume that might have been a ten for ten match perhaps. Yes it was an exact match was awesome. Sister is a senior at the academy's actors like frank. Steamers that reflects well. Making sure to keep a schedule worked with the sisters schedule them. In between graduation. Widgets so. I was really fortunate to. Match. A week later after such a perfect. It worked out I was able to hurt at mission. And I. Speaking we transplant a year after the transplant something significant happened in your life tell us what that is and. Yes so I got engaged. Almost. Exactly here after the transplant which was pretty special. Dan my fiance was served with me through the whole ride. So it was awesome very exciting ends. Its focus on planning a wedding now wedges. And that. All of that in the past years. And he was right there was Hewitt said he knows the real deal yeah really just aren't as good as our guys. Yep it's sealed the deal. And had a question for your doctors is finding that match fortunately she had a sister without match there for the bone marrow transplant was once the match but for those who don't have sisters don't have a brother that able to do that how tricky can nappy. Will things really change over the past five to eight years the better. Twenty years ago we would only do bone marrow transplant on a patient who had eight siblings a brother or sister who matched. At about fifteen years ago we started to transplants from unrelated donors volunteers dealers. Who were able to actually provided the source of stem cells and actually good outcomes. More recently we've been able to even use half matches so even a win eight other sister does it. Match fully ten out of ten match dale said a week you actually get by with a five of ten match almost as well as we can't attempt. Our friend Tara who's going to be here tomorrow had her bone marrow transplant in November. And I know she was kind of isolated for about nine months I assume you've had a similar sort of regiment you had to go through. Yes of the first hundred days I was inside you know sort of contact them on in the outside world besides my family. So I was definitely tough and then. I work for an Austin Co. act Clijsters and so I was able to work from home through the spring. And they were awesome. Sort of helping me get through flu season because my immune system. Receivers susceptible to catching something. So yeah I was you know at home until April. Answered just get getting back in readjusted to you. I. It's a real family affair doc watched any buyers Oprah folks beyonc really all came together it. That'll give her support of actually help keep healthy. A community effort. When's the wedding I'd accept. If congratulations a couple of things that couples swapping one you do work out some companies how to increase in credit out of great Fredricka. And secondly in the scouting reports and future sea dogs that we should be looking out or. Bully doesn't devers Africans as loyal you know he's doing pretty well. Commandant and the obviously. I don't have a scouting report right now but I'm sure things. You're in the nickel you need a great little bull market. Yeah it's I'd love going up there and Ankara practice hitting get a chance to. Endeavour's much he was there are very now really kind of scooted through town and yes. Now he's here hitting home runs things like every every game every other game. We took into been intently from you two's yeah. Yeah I'm not a you've got your children to this point yes it's critical to see them say it. Progress. It's to fat cats watch. Well it's great to visit with both of you and MacNamara fallible Malone multi faceted. Can not just in case you didn't hear ripped up. And doctor Robert Lichter thanks you guys that are very much for coming in it's great people that it. Thanks for having classy guys into the past. Thank you thank you and good luck with a wedding thank you and I hear from September whenever that is good luck. Think it's.

Follow this link:
DHK - Annie McNamara, 27, myelodysplastic syndrome, Boston, with Dr. Robert Soiffer, chief, Hematologic ... - WEEI.com

Stem Cell Doctors, Adult Stem Cell Therapy

What is Regenerative Medicine with a Stem Cell Doctor?

Regenerative Medicine with stem cell doctors is treatment that regenerates and repairs damaged body tissue such as tendon, ligament, cartilage and bone. Conventionally, when an injury happens in these tissues and pain results, nonsurgical pain management provides a band aid approach to mask pain. And when healing occurs in a tendon or ligament the old fashioned way, it does not end up in a 100% healing back to its before state.

The Regenerative Medicine concept is to shift the treatment paradigm into healing the tissue rather than masking pain. Traditional treatments like steroid injections work well for relief, however, they do not offer healing potential. So Regenerative Medicine utilizes stem cell based treatments that offer potential to heal these injuries by providing the bodys building blocks including growth factors and platelets that promote natural healing in the body.

What is a Stem Cell?

Stem cells are made by the bodys bone marrow and are a clean slate. They can differentiate into specialized cells with cues coming from the environment in which they are placed. These signals let the stem cells know which differentiation pathway to go down.

Stem Cells can turn into many different cell types.

This may become a skin cell or cartilage, muscle, bone, tendon, red blood cell and many others. By putting the production of the cells needed to stimulate repair into high gear, an additional supply in the area can provide the difference between an sub-par result and one that regenerates back to normal condition.

What are the different kinds of Stem Cells?

There are two basic stem cell types. The first is called unlimited stem cells (also known as embryonic stem cells). These can turn into any kind of cell, while the second type is termed limited stem cells (also known as adult stem cells).

With the unlimited type of stem cells, the cells have the potential to become any human cell type. They can be replicated outside the body and have applications for many human diseases.

Limited stem cells, though, do not have the same limitless potential and cannot be replicated outside the body. They need to be either frozen or immediately transplanted into the body.

R3 stem cell clinics do not work with embryonic stem cells, only adult stem cells that exist in two varieties:

1) Hematopoietic Stem Cells these exist in human bone marrow and are able to differentiate into most cell types.

2) Mesenchymal Stem Cells (MSCs) MSCs have been isolated from placenta, adipose tissue, lung, bone marrow and blood. They are able to differentiate into many different cell types while also assisting with the human immune response.

Is Regenerative Medicine being used in clinical practice?

Absolutely. Over the past few years, multiple regenerative medicine stem cell treatments have entered clinical practice for pain management, orthopedics, sports medicine, cosmetic procedures and vascular indication. These involve adult stem cells, therefore, not considered controversial.

The various treatment procedures being used at R3 Stem Cell centers are:

Medical Conditions that may benefit from regenerative medicine procedures include: Tendonitis Shoulder, Elbow, Hip, Knee, Achilles Golfers or Tennis Elbow Ligament Sprains Bursitis (e.g. hip) Joint Arthritis Fractures (e.g. hip) Cartilage Defects SI Joint Inflammation or Arthritis Facet Syndrome Spinal Arthritis Hip, Knee, Shoulder Arthritis Headaches Occipital Neuralgia Hair Loss Peripheral Artery Disease

Are Regenerative Medicine procedures approved by the FDA?

No they are not. No statements or treatments on this website have been evaluated or approved by the FDA.

Has research proven the effectiveness of Stem Cells in Musculoskeletal Medicine?

There have not been large studies, but quite a few smaller studies showing benefits. There have been small studies in both animals and humans showing the effectiveness of several types of regenerative medicine procedures, which are described on the individual Stem Cell Treatments pages.

Does Insurance cover Regenerative Medicine procedures?

Insurance does currently cover some of the regenerative medicine procedures for the most part at R3 Centers. Insurances accepted include all PPOs Medicare, Tricare.

There are certain stem cell treatments not covered by insurance, such as for hair loss and nonoperative facelifts. For those procedures, self pay discounts are offered.

What types of doctors offer Regenerative Medicine procedures for musculoskeletal conditions?

The doctors offering stem cell injection procedures come from several specialties, including sports medicine, orthopaedic surgery and pain management. At R3s Southern California treatment centers, Medical Director Bryn Henderson, DO, is a Board Certified physician with extensive experience in adult stem cell treatments. Dr. Jose Dalprat is another Board Certified physician at the practice offering stem cell treatments as well.

See the original post here:
Stem Cell Doctors, Adult Stem Cell Therapy

Stem cells: science prepares to take the first sip from the real fountain of youth – Catholic Online

Theoretically, eternal youth is now within our grasp.

Doctors are close to discovering a real life fountain of youth that could theoretically enable patients to live forever. Advances in stem cell treatments and now, tissue nanotransfection (TNT), which is a new technique, can theoretically provide patients with the benefits of youth for life.

The fountain of youth is within the grasp of science, but so far, only for mice. Human trials come next year.

LOS ANGELES, CA (California Network) -- The quest for eternal life is ancient. It is mentioned in the first and oldest story we have, the Epic of Gilgamesh. In that ancient Sumerian tale, only Utnapishtim, a man who built and ark and survived a great flood in a story that is almost identical to the story of Noah's ark, knows the secret to eternal life, which ultimately proves elusive. In the centuries that followed, people have tried every remedy imaginable to prolong life. They searched for the fabled fountain of youth, and according to some legends, bathed in the blood of virgins and children.

Today, we know none of these endeavors would work because ageing is carried on in the genes. The only way to reverse ageing is to manipulate the genes. And this is precisely what doctors are looking to do in order to produce new cells, and even whole organs.

Researchers now know the primary difference between a young person and an old person is the number of stem cells in their body. Young people have many times more stem cells. This is the basic, underlying reason why young people are so youthful. A young body can repair itself more rapidly and thoroughly than an older one because of the number of stem cells. But if stem cells could be injected into an older body, in quantities similar to those enjoyed by a young person, what would happen then?

Nobody knows for certain because the experiment hasn't been conducted, but the hypothesis is that the older person would become more youthful, healthier, and longer lived.

As stem cells enter the medical mainstream, and may become a standard part of medical treatment in the near future, there is another development that could make stem cells irrelevant. Nanotransfection, abbreviated as TNT, is a new method whereby skin cells can be turned into any other cell in the body using a special microchip and electricity.

The device, called a nanochip, is loaded with genetic material essential to turning cells into other kinds of cells. The electrical current enables the device to inject the genetic material into the skin where it ends up inside the cells. These cells can then travel though the body and take on the properties of healthy cells around damaged tissue, facilitating repair. On other words, a damaged liver or heart can be repaired with this tiny device. The advantage of this method is that stem cells are not required. Your skin cells simply become whether other kind of cells they are told to become by the injected genetic material.

A study affirming the effectiveness of this approach was published in the journal, Nature Nanotechnology. It has been tested on mice and was successful in restoring function to non-functioning limbs. It will be tested on humans within the next year.

Scientists have known they can reprogram cells into other kinds of cells for a long time now, but only recently have they developed the method to do so cheaply and efficiently. The actual procedure requires a chip that is as small as a penny, and takes only a second to work.

If the procedure works on humans, then doctors may have a cheap and efficient way to repair and even replace organs. The discovery is so dramatic is it difficult to believe. More testing is required, but it shows just how far we have come in our ability to edit genes and reprogram cells to grow specific forms of tissue within the body.

In a generation or less, it is reasonable that we will have unlocked the secret to reversing ageing. Of course, this discovery opens a whole host of ethical and philosophical questions, but that's for the ethicists and politicians to work out. For now, science is about to take the first sip from the fountain of youth, and we await the result.

---

Pope Francis Prayer Intentions for JULY 2017 Lapsed Christians. That our brothers and sisters who have strayed from the faith, through our prayer and witness to the Gospel, may rediscover the merciful closeness of the Lord and the beauty of the Christian life.

Read the original post:
Stem cells: science prepares to take the first sip from the real fountain of youth - Catholic Online

Stem cells could treat patients with Type 1 diabetes thanks to a new implant – Digital Trends

vH7)`H.Exr]v[rU: RAU_D.H,U}_b-#>}?<.>|'jnP>N u$~Nf s=vy~hig~:#E8>:5jw_,'JXjE%ybyf]8x'bkrilv-N?EY0Em$ 8]L}W3 w,wIoa8o]uTkgjMhK<(hg~8l9n-o:KZqNqs (xy7`xah2l:$IKeY+OuFJq{Lg7 Ztb{; :[@s;vhxb^P!cxF}w&J?PA%/%X?u8]@a}7${g[ B'@7`#` qy=VVGS_O[,FNzFhcm -oS#b-MUI74vb$Mjjaa%EWbR%g~7}cOz.FOrxAC3/hFp>J =zc[o|(Vw9#W B$ -{mzN}5?>Y't&c?NYo-Va[0HX%[f9)v.W7m:b+, g7?kN.3t:zX]f)kzU qGwb7X 2l?z/= cVS[y=&zhsKRl+`r-+ -l?7;~,inz(ckF|cSGa Sb4jnd%!$F/^X*#j q#&wxi, '6R, gnMoJnphIVi 9_/y4U}ijtT#1#Ul~{-kFPfy)&KA{> KL]"RnE*#S/Ue'1|9_v]4yc]zc5B=M <%l|32=tc '28sC0,~|fc{68 'NdF{|ZCz^lrx5=<;%hjjVW_o|b}| J)@lr"B} rdSDL*Oyv,0=yX_-[MhM. 2 K$S;27 k& P&aO&+S,dho$'<6DVpDa;]j$I 5AliDq 3z0Yd4B*5)zZ*-TK;7v*CBVHq{n ^(WgUtTbv8Q 7jYq4[|yG?@m~KEU 5pF626Lgoz7OG9w,dD?7m;yYaxo;ulEx~4]7Bzv)A)uF|=T8~1^SDsX~K^Z~1W;No{kKosn]yAww$r>KZ.}?1OV0@Iv*|TwQ vNY`zo8vmakn3hCy+Lfrb:StN^y6YAUb{h >lI)B2`yRxFopDx?m:J!B_p`PA|h#an`Mzh,7Fv4CJ6.HQfHtuz(j[7g-RqGm[j~j)IIDb-"Aa57v7&u9a,)8[RT,d[CNmu@n;eR7mfwmmmsc{.$:;y([;yY<,NcQ @nnKA$(`%Wk6?_1!^WVjW{2C>~u6j6mIWV3'gG[oL4[6&[I#i~u1%{}pE&++9YKK/q';wjX~844=L258z/>W|/(^:Xk~jt[u6w5kuM[6*hLvvjhD|1oNWV5B#n6 PCq>m*U#h%Vv6_tSr<" *2q_p6 /]3_#iF}AnArMm[6[UNHft5Xnvi81(VD#@#w ^fY+9<.a7eV <, M9i~I_WLxZ;CVF !Z0ZY 5/j c>fbYA0?q$,Iy3H.t[$x4Y5Or$!djK`:=79lpOrj@L;b449' $F<4ZF g$a">ZP`K$ 5,N~kLT B%`2[!O4??|G./<5?fl< C@m ZW;53ior"Yz_= $1vp"]e5&+_ HmH_ "0p Jc@ZwY9 s(gtHkIs0@%ms *T9yL#jEiU[o0"zcuDO0 $eLP I|D'1evGd=L5W#Btn1Kk@s

l~.$;0Ng^)`9bC+=xp[e=w7E6O u0- 8xJt F FlkC15`3y)B_U*hS &~.@uEc6D *7LT":h'?IBL>8P4^/pa- "7Y~Bp^-yJc}ij~Rk^+IkP8yuEKdTpf1Js!U3x;-S9~AB>JV?'n id$Qrf'P6e[rHGUiE]0D~xmIR0 p{>P)%SA?hER{XO.B='Q,L#d,RIwT449;Mi (Dh=EkD;xC`:~"wnX$(] O7C _~?L!%zzz1_1bS"O:7Sm%qb}Vu%B,plp-H#dm%UjZJ /E8?uFs/j!m9oVUovE@E==0>_( %iOdbb: sX 3"^6aatX.yiLLc"y!sP0ldi'sXO),D1a|m!K)xBC#Veex.m d<.AL9qcLB h7%0OZ8"aW7a6bzNtiuxfec09H51XzX29$akK!hd >fl)/$">SO0FxY/Hmh w)m7O"(/K=2 ZpN4$Ua%nYBQvkqH!l-$Gg+1D[DM*E0cvK:awn&h/:zGE+{]w O-L!FzFsA->[^.858/k89)DxB"]4'~}PzaD$SH[SMB4|d&< 2"L;;"PrRYdg) eM (F|S{>_A%Gc$3&Ga"O Ix9Sq-v1GYalJqc05;/n"fo5W;{pu54mniOW/6E" d2kn{7JgqqwIdo22EpPvee$O`nI`G|, Y&q4?k+'bdp Yv[.kd:'qt"A$K%?d>S/c}GEG|%L" 9VVwM u=l_0<+F?3BFpU@j(BK_R`'rT~6r ~H_{uT9zr^f9@h*lk" %No/ 2M2Ps/:& $)C7Kd{jD$!l*ZiSkfSkh +F'!=--&WzU;5y`RZC7!`sn4Wk}U:Woiu8u0+pv3!W`*Kv D4)&8{*f8{>)|r(sv~~]"KNr}vL[TFA2rq9-DK19VFK,#?NNObU!"_7OG/Cj?hR*.b4q>Ic!Obh{%p;&v8!^=~4H~0[@!&O:/-SWaX 0|&JY@L yrq /_:u"|0aK/|g >0p5%U

bo"$dGB/.e*5 jT8/%SZ*J~YX1M)MQwJIAnv{y`~(zt"GszZGo4Z@=6Q]!`T QvN?sGI XQy8,tRt~;qxJRDI~+mF'%XXp!x.j6E"dmF.h2ot/p$%F`Yii`C8)HRP^KBQt8"7~X**RCT ;`=Bg *p+UZp]+%tvK,3RMA2E*q R5T h"))PaL@|fU65[5bP>@<5R~;jf8=isxQa=:*mmnll_ dQO0;0Sym%6xgEv{u?Q~lo%>G#=r{n@HUH)z6t1C:UC6jt /8'GoM/-)^/+; @8;u0 @m?A(5~KzD[| )j$|FaW] K[ |5nStGq^5Yc`>aUa:IF+Ob4ap+%LCoq*sGR 8 "7PwLc,jer"5l}s1[);2k\Z0rZug6O^5LbZN}EC. E^obxmaB=fYN}k#E*hK,HQ*'{CRxOlj7VtFFHW_bOrrt:J%*`J+.Rs^TCuP?Z O`,YUE,_=bf2CmaAB5Som24-0 U$}8C)FurW.HS (gj}9#*3j&c&+CMg09SdW~DJWm/tA~{%_5o9J<9OtFx2dIG0MQH$)M[YheTlSi0% aX/-%H$:3,TnfE0Fzu^LeE&Pj0'vBz#I9pWz(C/RHX:L*yBVS~B $G?$W_^ t{ggJAmDY-z +[F^E)'^=AS/,G.g-(5 _|JNQH.~1Zk$f>Oc2H_>CiQ8&l2u%N.Ea ZyX0 f}OOd=#^Y;K`kg<#xZ"SKWVC@8fY hv]Gkkp'z1Qm}s*IRkf'_m~BuyH73S:5+#qD< 7J1-h5Il7jb9SpheMG)44.)TUgsR,959 S;p< %~G1:`'XHxDV`p`!^Q:@S4O'xYw(rK?^Q=H?t0',OF*H#B#tt4?OB1L"IZn{AM)mDo]!J6{5Kuirtwd!F|; D,kx7dboj|FG 2t> ;w,Z#$N:>>9Y>Id$ } k!QZgdDS9z|b&A[("fkyg~E0CS#L1~H7#_!IZu231GR/>6,Tt^K*#,_A7L"X)} 4.% 6y&7}B)/}yYSo IHoMmGmS5e?4n=w G0O'[$3>b/<|A|5bWmTSdb@l"[OJnvU(X]vkks:Hgd#>WalTpIh.8Uup9A8'Ttskw&]Zu 'EY>&1i<$*L:A/$Sw{"F ?xV"G2tQQvfZ0P2Ve~~VDReKUH4'?[WPNU2kn*o`88XEH^l5Ou!6?DO[:X*FDy0S y2dwAVI $;'Y+JaW^PPLGg=Ov*sm*Wuz_nHc*ln"#aV[4dws @{lgT 9!^y ~UE )R]a|#x$=9:4n8$/Y{ka+'IdZ$$q+[c`WqXevvPDhNu`Q{e/U Vp~nzInl@ }* Syuzlw,2XXPUG0bFk@%=dX ~nH.rm DVY ~wEyvo}B3y^e9Gve $"Y0lup s&)bBb:_na~$sNU 7,[O,Rluz5]J;)%@F0nzLe"C} F60g"mcvz"RS^omg dY.*X, D Tt9 .H'IDy(wAW#g^?L|PXk;wJV'w74FIBe[T]+ kl.oe-`BzpSa1i<9U]5%9( DoC}Ejl1QEErWYd [-a+yfLE:y&.Bq'@&e:X--Z~!C )*aC_MOgSDU*% z^(dcNjtECXM{ sN -~I6F7*D`Q AQGG})T/cb3`4'3Iz@88 ;ph1[ydQ:j'WHO:JT$oo{l5gog}UyQNNNZEyd7Y0&9:@!*A A, !idL?<_`E*c6+ n LH }xBRbP :Pl9h.])R Q luK(IKEWWuKPztuBZ$7U'BVus3F% {#n[ovurP0,(Db)m3?$DX*yH6Svdt+C}t}GdPI!)=$C(a"HBmTd)2ndXlpP&J@^_V_S8aYh+%uyRL25[@n`-lVL4,04opCg4:dZRzXOf>l c-qv,(hXCx$E#]bp,nd$d5Rlh7w79*lf0 ]mkV[vEU.%Y$*q-M-2Y[R8mE&`t$o"Vb1zEh8KfSt Sst]H&N(m%=V: d!I?^VES3EmV0{-ZYMnw/`_393dq[t__x-Nf/3sZ-j{GK*4Y-q;HinNX_- SiefC ]H&}%(|bH:tx{WeYzwJ2uY9e(OJvf0mWRJJ|v,4g&[[;@nG: SG[7Oo8&pv>`]Q}.w2InHx_e]) si%U- :3WN,Yp6F#IRAjY>e=L"[ );?*HBH$TU6xqD:6jpl);5VSvC$UV2/jyI:6jpXG2K)+c%Fn58i84i8:piYl%9u0I]rofb,n4q:19[ ASGy3 p%|T6vQMQGQ7@o)o{hXf6O*ps8bK`B_=56,9 kX+,P4!JVK~K9p@*Wij.L|,5Tvg)oXqcqHa(Y UM=v8aH? )V1SF53vr7`T*F.rl;q*+O}T?4'>Nk-=J[(+&17ZThF-~,L=] JXzdL!,AYp|FLx%eL94 4_!4 -C-|>N _ 2:F6yD(T<3@xP?VEQ/X9", ^#"Ew+q!QPeP.1f )xqr Qh ;wbi:Zy3*zL)KHP/zY5>eU8m7|8q1YA]Jp8!k$MB9tpV:SDNQQ}gDda&q}}zfwCF o L"hsn=.@}|g8nq4Ea**WVFN*rM3Aeqc%C"{;_,Y/5j9}8^ TQvZg|r)-$=u4q7T&G%kj2tAardz#qO)&lE&+)=Cr}ew {T>SEIi_0[^s R tQl q9 s )J> jy7Jj(QG:Khdc Z'{e4Jyv+C*^@@*C}-5t(]@1|b4F& I+(ux])#fQ&3u~||#ki(VBH=tC5}r.Ht3Cw,en>#acqd2'3V&.k{y u9W~? {A af Gf1W@~L8F[h;02Yo7Fr(@zBadyg^y+L+h%q"rBR%FL=Q:N17oa }<<, [))pYEa|aBBTpxvhFsFd)(v$+Z0gXoOp>:[N 7pdKgv< dk1 %hsYI9g|1,R` 4ZlcMvs11y[G8r1doCY +!@>xRB"yu,e9bIi2)x !#Nl%w 8lDSphGJKL$-ol i96T "8; CDy2gP0O *j;2@Y$)AD(_z?Bs@6cB4O~!OT D1}$)mvR"n(nAqXC:pC;e.CR7h(aqT4/IgH bDit?g,dRjR}-FNd7 -7v!x; zOE6'C1nyD>$M(Ef{^$h3BJ$;`%A |YOA O*$*II`um[l z:ecbSCSowFa8JS%F0s)A.S, P4x4N4@PLTrEQ]B$I #e`gb1>rCV07S@L(AXG3L# AfB*EE+-uoFO*3NC{4`l4?He%ljcri.^r;#)?G:7+k1u?st+Bb5(l;;8r o5bcO:y$BE9-h#gBJ~2(I4%$9 "+t9H&`q>GeF'^IA&meE~)~)Q26w0E]t>8X8 Q@iuB*&AP^0nSi3Z>x, BV,of7zDLo~;;~q5Fl'$QHu{c2}(dB?#Kb_) ":E$LB#T(/F@!@,&@hYr2BrZ"`J;Ggnq,KR 2g22+z@glkMXo#b7WbW! |(_CDpjI;q;3C@{bXrl+I :_aGI_5jlRYt^BTo8BgLI]mm6:F}._o)_a q&F8H$}RSmjUw>h 3z)m?I}@bK_|@6fDLW32F7TnzosEgp,x"=M^fnPx;SOgaVO(7'{PI5>o:N0!D9L@zGf~3g&qh#*Eb f[OTj/Uih09oqZ- uiJj`KSYPfcmcE&8$un2 Kkzu(EPr"$;}>nOAxE5qvpq7*P#90(0C;d uVb1#z1q9U7Hs2>/ 6) B|92|1z64B+!|P^X>+0^I/G$M[F$LSkqy=[{Y{z*h@!UK0L|H_'>Z6B[U>J5(VnQ`aa'FI[+Ru^a`U1#$(;ne 6; u"2&kP@*N@oi/ KnUq6s"T fF&d# AK[(X}I@ty?8EF;E>xNL`@oK)loV Euj7p {8Z,r'9B ?Qx;nQb+pb1o> [ Kj=Uo C_.Ev(nkh :-dY,QsU=IU~_Sc iX/5%K-_s4K:!7sIJ`B2CUZqH- LBt|.j T/Ocq6FF!4gqIwR)aH)9}U)+g@UJQ.o#'r`Mm{f`KA]@i*12} *]w3p4v==l<:!gpWNqa*`M;F1"1vA.Vh>(>d;rBU:YL.o_&9]?} M}ad'!CKF#!AdgEr/2#)7)-" r$ <'H@7C)6fEh6J990Jq ^l67F;2aH@G6x`l91"2C[Gd=Nr!#!c[iH7FD<Ue0(h8o.U/N6dc)m17DQ g^WL';ugXbaH%/b>oLtk8XEzi(-G+*67%?K|C$(;pm2H(P73ajUe1M 5~pH2.7CHdo(XG9@Ey$T,C&6x7=Lf>I(UMA"O@kV(rpbGTYHtD)DKP~>U4iogr-Bzf)0212i.%$eB J.&]22Z-G Gofqgb:raL, b&KrvnG=[`q1xkK'Gb='y]:/*U>!-%4%U~J]n 3if8bD2~ zM#n'HP-|o|7&QrzW`R,u$-Zg 4)oF:m1u?8fGx$v?,(4g,Pa-twoXR ~xbo$XQbfT d4Dwqq"3 @2I|{Poe$$Y-erTft-{ w6mw>Fw&v5$>D=-Y Q ztS P%ZuL"p[`yqaji>Q:~8o'$#6H<7aa1E?/&wsVqF`G5!ze[2W@;s+{#B cxH;(=P'nb *p5td95q_@kHD&| <6(3# iGP<3eo<0Q3c|cZsF^O}{U43@z6xOSXsOd rhkem$acH #x5mCjn$GI>('@fVJ-=pe~m]CmsY,04`ryR) GFdW(%]ab #>Q4ijk?fKW)b}Mo#ndc'V|~|sp1'& gS3}~{1~1to'/G%-4@lB5:m9]LtyH|v| cJ]d]f=$`yKQI1(Rc$/DPCf3TjryQJE kUxQ=WUi57DGkdAut_M]f:o9 UF%Zk.^^S1qJ1cn_ ;:okME7%r30o@KyWtclXcx#3n.:[2i?nq)N^|:4iq+W{?Er'>:{lhVJLSSH.&U?oUH>[d?[c^1zN!-REx[|axuun*W BQB{F-*6p2bLwR?FY:WF+vV`WTONMCL.$~.=> oFAE?J/HTY0iN0/m|O|7^[4k_|DU9Sn&6bJvyR|&7+u,b5*/s5fRJ]-|tL9J{_,Rc_[YagohO-^~80Xal~m0p^6;A{5%t@ w10f/R&*Kp :Tsq iKR6o0#1s%!M `QfI!a3Bw|Ct>y r>Zxn%yreV|Its/yiMwjRY| ;]p6D,]iKgp'J+k[,-R'l:HTQ0Y&PJv%f~O*30zYY759w DZ.a@{I9o`yu A$S6i ij/mkU p6z) i?rDk_R(^,te^zMO{Cn`E/@3k-t|M%m:#BBmGM2@F/T-J=cN;8^qPVNMb91_'l?!9i4NOF(N}L$WW+40TchE [;M+)azo_8}}}%cJ[-;#:idISry6?*[|^5v%Z;S~RjKuu fEZW0,I3V=4.d}d2W(?2A?/v5Z]~)P8{?cRpupeQ6` 9D.u]/w' R~uD)qip #I/xOe25'lv$^;Y~!"+QHAdq]n$vm;4>ji+J3u}"3*cr~>E/=pO>~ m* 4G1n0%,DyvTwZvP2]Y[v#dz>32 lCy@vuVy%X }k:dqT)M=K!eQ8rYK]D$JMWk)UqA_oje .-be:MfPZi=,Zf376[zEfV*K0HIDgmty lEkyz="?34zdNs8,+%W4H'XRU1=/+R3501`G:f0 jty$|XE,#}b'UZzQ0o/h-]%ew88sw^maz{Wj7{p(cHgj~Ou" c-u*;={0uz:RN;G0~t K9Se1KL!d&IzrvQTi^d)vOvjyH'{*pc+} OLOTq0,iWYF+~QAWvN~R m!/2V ti) E'=Bi?T5N!rNj{TD!Xl$vgidIrJf[k6sH6AB8}0%;N}zw9d1 V/6GER`v= bKEc@W|f6ja]Q$8q"e=F+kR>E}v>cZh'M2o|[_FejLBGag-U[#riRC^MS:Xp}h|: plL>~ize&ab6Cp{qe_{5k&U!:E4;hp8qaLV:a^a=O:P.x%dC ~ocY%'h,#@,}Gu_BP!* ?]g7.y$J3_4{Kc%>'i"5!"wBbqiaXCWLgt@@9n)BJ(S WW^c*90M=k^{y77@rX[R[bLHD[_XfIDA^@g(k#IN<ZAN+K_L]N..)@s 2,B,?Yjr_$;Td>1QTk,X[X+O'VdV=W;~ me:-H:z* . Y]t9w.OB:1Nzj#[ptAz)qw"LfyvdYWPAS#rDy;H /G8OJcnWk$W,$z.! F1Kf'1/Kn?gBq{>kM|peQ.Ts .}+^-:-XUc?PWv}1LkUv=sl~`|tq *EJy[R3tZz}L= db ;Vx)9adANt,cL.ScLp_v2Dih7;4]!DvueUa+ >5>!/$n=W+G7@\,c~%cKF]|6s=3&Ap5+#7d` fj:NR|C5}L|]C:wXT6D` r2;!hPmpN=/Ss#o &eZy?Kxr}wvjjt[` n@@B_i_L0gg"?Tc["Neh2W'_/`'lB%R@I!5c(M^`pgc'hd)U[QUf$SEbNoZ{ e). =#=F1y:n Q1QjMR7DN0/H4H_gq~x|6bwKg$FwRKfL8VD'|~ZZ7Rg9EH rU25{y~hmW;8V2P8-*4|x08_dky4s6hhr%,"v{s4)]WspSG= 8&#oa/zBFx4fe{w'*ngz5=qZR}Y6!aM8Nt 6l4srODo3!|_Mws2nz==r"&OQ !z"@9"1E%g. KLSsBGw"9k{Z'UI N VDd7/q/*H 8Y'O;I>iL6J#z95+3cU.bML*c+>JmI!9d5y}3@!M;Q|>"olY4,z.=;P}; |mmM!Lp;]d;IX?hwU+LZe/)IASSuS9$ q59NLCV95V 'Q,6d5;L{ulujrjE-F>8Twuri<6k>RQ,srwv0PPPvQCu+NbuXMoZg~AI6H a <(K>[nKa+fZga|3/Xz]F Omp=^poTn0v#I'pFtWCLd(-I<<']aQ7stbdB!@B8P1^>Ncg^j/.M`S+Ui<8%5 PgnmW`lsg-YapfTdc`g;m/0L]H@QF*Ad95lw{H`A<,fK[{J;|L_SZ=QwW3w;)y?{LN2=xs=/)Iw:'GAw~UKOB7j5P`d|9+^Hd_385dFa< U<2w-4^0:o_}X/QlgU;m8:5iQnvF)#0qT/;..i'VM+J3m:LMf?G>Vp1Upfvd,. xsb;E:p,e0 /JT~[VIf6I{~Yv-Out@Z74Br tkTwbG 7vCDjE=g;@wl.pq9mY],YL0^^.k{vKke=|vm{wZjPt8ETdrD0M(kPW@>1[oFzU -yp5=RG !8t>42."[g|c88SL? Ss>bXym}lE:NDN7ag#{F.RH|_vmG]Aq2z9"#%-? ytb7S~g0D%"T`2f%Y|{mBc1yLm83ZN6bcEqM*tGDSj>u8RP?=p;KxGd `rl=2f1[;sJE#=TgGo/q,Xuc58GS"M|pa%i'[fD3gj$;* nA$(jt!GS6vlxTEXBXNc6B;927dErEuTuQZD`r!F/(kkFb1(?M;M{%B8/Uv0c",{ZqkV9 Tq2QfUQ,Hs^"F5D`_N9r3t`y^Tz^|{!dg WZwWX+]^+@CHo-W2datI63GiOfchlp`}E>BKcgde_%MJB@F[amC}?3 NGQho{a'PR,=%zNVFAV=;6vSsR6K}bkgpYL.*-g@`sRFEv9e]JY.H$p{BiT@KSTQu]MbK.h*")xJ[n'"9 .r'h RT eqqeE .ZTZ*{w4e%4TubFHm~ZM! qL7HfVtrPid{_Fz+W^A( )[8gS(f|JWs?1u]5SAIc|"nI/x!lik A.6#p=6S| %#UpIkP550ka 8N,l, yZYJI^1TL8~8MkZ)#%g!uizF^D :!K&jG.| {`9 D!eCuU_ $ 0xh$RC5|9^ |b;U[AVgD DMrweC-9Ic`|fD$A2=:A7Cw{>IQ E11,7"I7YXdFZWk ;=D-/Zcd5=_[`S!d {*2*5e e(CB">>zr5l"DpovdE.^f1eY;P;rBdO$36W~m_7[[cR:l.Xen` *~U :pdUR`"|.4pn9ltu,4;9we,eNs r[)0wcUE] j&T (,O]r.$"8r4bgPMeGe{JrY/-}!;# vmn&* 2V?e@X,(;9UHM ;X =&-IAT+eEztDl}'J' 5FZj{/{edr-LkM3`;7;'~JB_t/el>NcKWA|j9scYt]ofE=E V5Uy6)|obB`alk[Ne^?M&[u9"rFDE(63 anak(g4l3]w ct0.cp5:2'zN0;ucGNA3vW1e *Q|MrrX9.] 4!bUT_,KVx j^(yXH}$1|iG2W L3JkQq VAqN'mhS`_1u5uJ]"JoU}N@DN!c{+(r1'k+egbxl[Son([-_.lj[vq]-]sh6HDQ,gGZ9$E" 1A&hkYsVn$u;;3 ]*H*r?[S?n",BV-)(,3M!Tx$]s0+#%l-t-KH-5 sZeUO:PZ>ILJe{Agi;eF[adi4 8F`S}hf&p] C(m2UM,(I9iNj Ywd[ughaAW*.xKwvAQ0KXKits1nH>|6mNb2#2;oQBW/+e$7*sa8$?DCTq+kc4:&I6r./2u9p=fxQQLaq+kY-P1qy5VrZze u $n/h-%A&9RaE8H6{4rGxj;-?(rXZ:q[US1s$*W-8S7L^#qYVP)9<^^.k{vrjS/Wwvugo[eW_1W)rja;s2NujuOy/& S1{y_ow^e.S;9!?b=;_n8|`RIuGM!2{mqIxE p H H59Ed_}h0I'&DcS1.iP'?(aNoKk._?oh||i|RcI~e_$L <]=+~!]a?Q=6fm00#yfKS-}g/*lh<3=H];x}fr9:5 ZcP^ 'eoZS<{(}wnO&'z9;4})'*[6o"_o9DOh_}z:sro5:'/p22p zF1nDGrz[~wz2g-X>&q5KQ}r>@|]S?g7}1r[K7*R"w;|j+77+Q3H*#QoR6pmi5r}iC&qsrs5Cl'deWQswNdx lqx:Md#"v2m%K%yoZzxb+YWG n} Vw< D[[[ (;yl7l]}i1g1"o"YPmi{cjJ[K')qfkGvoX61%[F%O|Z/'.;ol/y W?aGodR#B;YZ=S5}=Ff==>@{B7uk06QqyII>-e/sno=pe{enu_MovzAe]=S0zS===K'{G'Lo~:6^ou;n]Zin~rLV_tN^$&V 9zSE rB[kNU5?I/rTT?X|io7 nsJVy,EJ.<: G7Vo27^M`xLB`{/,e205HVxHM&GO;EF}Mk:}yp9>eS?8<5/4@PMf ?s7U:ja=$+{BS_;<|CLjO|&.;:,w~F)C4^p-ghD}n#Q.?]PXZGxv}kzaMsSm>'&6;8SL$3|21Hhl&0]}fl8{FFC_< _}u;f yQg*O7?x)@HDH!6g8g~Y *a5YR]{}}eG& >ccU;U@mw5;c.t54enq2o=3lqT=ZJ

View original post here:
Stem cells could treat patients with Type 1 diabetes thanks to a new implant - Digital Trends

Hope for Emma’s voice: Child undergoes ground-breaking stem cell treatment – Stillwater News Press

DUNCAN, Okla. Emma Harper is closing out her summer with a ground-breaking stem cell treatment.

Cerebral Palsy and a Broad Spectrum Genetic Disorder create roadblocks in different forms for this 10-year-old Horace Mann student.

Her parents, Micah and Tara Harper, accompanied Emma on the trip to Orange, Calif., for the stem cell treatment if an effort to improve their daughter's life.

We never gave up hope that she would one day be able to speak, Micah said. We were told by doctors whenever she was much younger that she should probably be institutionalized, that she wouldnt walk, she wouldnt talk. She really has beat the odds. She can walk. She can walk on her own...

Emma continues to break through barriers in new and different ways.

Tuesday, Aug. 1, 2017, Emma and her parents met with Dr. Henderson, who is familiar with the Southwestern Oklahoma area, having been stationed at Fort Sill.

An initial meet and greet and question and answer portion of the procedure was completed. The Harpers were scheduled to go back the very next day for Emmas treatment, which usually lasts around two hours ended.

For Emma, whosebody accepted the vitamins and stem cells quickly, the treatment only took 20 to 30 minutes.

They (doctors) said whats happening is that her body is really accepting the stem cells. The doctor said that its like fireworks going off in her body right now, explained Micah. It was a really quick procedure, and the doctor said that within the next two weeks shes going to really start feeling the effects. We will see progress in two months, and she could continue making progress for two years.

There is no telling what type of progress Emma can expect.

Her body is dictating where the stem cells are going," Micah said.

Emmas doctor has seen miraculous recovery and progress in children with cerebral palsy. This treatment also has been used in early-onset dementia. The treatment has a 100 percent success rate with varying specific points of progress within the body.

While the Harpers cannot be completely sure this phenomenal treatment will give Emma her voice, other positives of the procedure could be highly beneficial.

It was a gamble that we were willing to take, Micah said.

Emma was feeling great and enjoyed sightseeing in Los Angeles Thursday after her treatment.

Arrington writes for The Duncan Banner, a CNHI News Service publication.

Read more:
Hope for Emma's voice: Child undergoes ground-breaking stem cell treatment - Stillwater News Press